8-K filing — LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Filed: 2026-10-20 AccNo: 0001005286-26-000040 Size: 142 KB Item 8.01: Other Events
Filings · News reference
Wynnefield Capital Discloses About 14.3% Stake In Lifecore Biomedical, Agrees To Vote In Favor Of Its Pending Merger, Per 13D Filing
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Lifecore Biomedical Q2 2026 Earnings Call Transcript
Lifecore Biomedical (NASDAQ:LFCR) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data
Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankruptcy
Major M&A deals include Valley National buys Bluevine, Roland Foods buys Savor Brands, Bloomberg completes Canoe deal.